Sunshine Biopharma Up Premarket After Steep Fall; Traders Track $6M Filing
Sunshine Biopharma shares jumped about 147% to $0.70 in premarket trading Monday after a steep drop Friday, following news of a $6 million share-and-warrant registration and a quarterly net loss of $1.24 million. The company reported first-quarter sales fell 9.1% to $8.1 million, citing the end of distribution deals in 2025.